Pet Allergy Research & Development Service
Allergic conditions, particularly atopic dermatitis, food allergies, and flea allergies, are among the most common reasons for veterinary visits, significantly impacting the quality of life for dogs and cats. The demand for safer and more effective long-term treatments is driving significant innovation in veterinary medicine. Creative Biolabs is at the forefront of this effort, offering a comprehensive, preclinical one-stop solution for developing next-generation therapies for pet allergies. Our integrated platform provides the scientific expertise and advanced capabilities needed to move your discoveries from concept to clinical reality with efficiency and scientific rigor. Partnering with Creative Biolabs gives you access to a team of specialists dedicated to veterinary immunology and dermatology. We translate complex biological challenges into clear, actionable research plans, helping you navigate the preclinical pathway with confidence and accelerate the development of innovative treatments for allergic diseases in companion animals.
Our Pet Allergy R&D Capabilities
Creative Biolabs provides a full suite of services to accelerate your allergy research pipeline.
Target Identification & Validation
- Discovery and validation of allergy-specific biomarkers (e.g., IgE, cytokines, inflammatory mediators).
- Allergen characterization and molecular profiling.
- In vitro and ex vivo target engagement assays to confirm mechanism of action.
In Vitro Allergy & Immunology Assays
- Mast cell and basophil degranulation assays to assess immediate hypersensitivity.
- Cytokine release profiling from relevant immune cells.
- Keratinocyte and immune cell co-culture systems to model the skin's inflammatory environment.
- Cell-based assays to measure the efficacy of anti-pruritic (anti-itch) compounds.
Companion Animal In Vivo Models
- Industry-leading models of spontaneous (naturally occurring) canine atopic dermatitis.
- Inducible models of allergic inflammation and dermatitis in canines and felines.
- Specialized models for evaluating food allergies and flea allergy dermatitis.
- Custom model development to meet the unique needs of your therapeutic approach.
Preclinical Efficacy & Safety Evaluation
- Validated dermatological scoring and pruritus assessment.
- Detailed pharmacokinetics (PK) and pharmacodynamics (PD) studies.
- Full safety and toxicology assessments in compliance with regulatory standards.
- Immunogenicity testing for biologics and novel therapies.
Service Workflow
We are committed to a transparent, partnership-driven process designed for clarity and success.
| Workflow | Description |
|---|---|
| Initial Consultation | We begin with a deep-dive session to understand your therapeutic candidate, research objectives, and specific study requirements. This ensures our strategy is perfectly aligned with your goals. |
| Custom Protocol Design | Our scientific team collaborates with you to develop a robust, tailored study protocol that is scientifically sound and optimized for efficiency and clear outcomes. |
| Study Execution & Oversight | Our dedicated project managers oversee all aspects of the study, providing regular progress updates and ensuring adherence to timelines and quality standards. |
| Data Interpretation & Reporting | We provide a final, comprehensive report with high-quality, analyzed data and expert interpretation, delivering the critical insights needed for your program's advancement. |
Our Advantages
Applications
We offer flexible service models, whether you require a single, specialized assay or a fully integrated preclinical program. Our experienced project management team ensures seamless execution, maintaining open lines of communication and providing consistent updates. We are equipped to handle diverse therapeutic candidates, delivering the reliable, high-quality data necessary to make confident, data-driven decisions and advance your program. Our expertise spans a wide range of therapeutic modalities aimed at treating allergic diseases in companion animals, including:
- Small molecule inhibitors
- Monoclonal antibodies
- Therapeutic vaccines and allergen-specific immunotherapies
- Cell-based therapies
Partner with Creative Biolabs
Choosing Creative Biolabs means selecting a dedicated partner committed to advancing new treatments for pets suffering from allergic diseases. Let us help you de-risk your program, accelerate your development timeline, and bring innovative therapies to the animals who need them.
Ready to advance your allergy research? Contact Creative Biolabs today to discuss your pet allergy R&D project needs. Our expert team is ready to build a customized solution for your program.